Join our team

As South Africa enters the winter season, the country is experiencing a small uptick in COVID-19 cases amidst the concurrent flu season. The latest data indicates that the total number of confirmed COVID-19 cases has reached over 4 million, with more than 102 000 deaths reported since the pandemic began. Hyrax Biosciences remains committed to supporting SARS-CoV-2 variant detection and surveillance through Exatype, its online analysis platform.

To support the analysis of Mtb data using NGS technologies, Hyrax Biosciences recently launched Exatype Mtb for targeted and whole-genome sequencing (WGS). Incorporating the latest WHO mutation catalogue, Exatype Mtb generates comprehensive drug-susceptibility reports and lineage-typing results. True to the streamlined nature of the Exatype platform, Exatype Mtb offers a secure, cloud-based, high-throughput solution for NGS-based Mtb drug-susceptibility reporting.